Lymphatic blood filling in CLEC-2-deficient mouse models.

Area of Science:

• Immunology
• Vascular Biology
• Platelet Signaling

Background:

• C-type lectin-like receptor 2 (CLEC-2) and its ligand podoplanin are implicated in lymphatic vessel integrity.
• Their role in preventing blood filling of lymphatic vessels throughout life presents a potential barrier for therapeutic targeting.
• Understanding CLEC-2 function in adult physiology is critical for drug development.

Purpose of the Study:

• To investigate the role of CLEC-2/podoplanin in preventing lymphatic vessel blood filling in adult mice.
• To examine CLEC-2 function in various mouse models, including deficiency and vascular remodeling scenarios.
• To clarify the necessity of CLEC-2 on platelets for maintaining lymphatic system integrity post-development.

Main Methods:

• Utilized novel and established mouse models with deficiencies in CLEC-2 and podoplanin.
• Employed models of acute and chronic vascular remodeling, including tumorigenesis.
• Assessed lymphatic vessel patency and blood filling under different physiological and pathological conditions.

Main Results:

• CLEC-2 expression on platelets is not essential for maintaining lymphatic vessel integrity in unchallenged adult mice.
• Deficiency in CLEC-2 leads to lymphatic vessel blood filling under conditions of chronic vascular remodeling, such as during tumorigenesis.
• Confirmed the critical role of CLEC-2-dependent platelet activation in vascular developmental programs.

Conclusions:

• CLEC-2 plays a context-dependent role in preventing lymphatic vessel blood filling in adult mice.
• The findings provide new insights into CLEC-2 function in adult physiology and vascular remodeling.
• This research supports the development of safer therapeutic strategies targeting the CLEC-2/podoplanin pathway.